Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
APL Research Center is the primary research and development division of Aurobindo Pharma Limited, a leading Indian multinational pharmaceutical company. Originally incorporated as APL Research Centre Limited before being amalgamated into the parent company, the center operates multiple state-of-the-art facilities in Hyderabad and Sangareddy, India. The center employs over 700 scientists and covers more than 13,000 square meters, focusing on organic synthesis, analytical research, dosage form development, pharmacology, bio-equivalence studies, and advanced drug delivery systems. It serves as the scientific backbone for Aurobindo's extensive portfolio of active pharmaceutical ingredients (APIs) and generic formulations across key therapeutic areas such as cardiovascular, central nervous system, oncology, and anti-infectives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on APL Research Center.